Aspivix

Epalinges, Switzerland · Founded 2015 · Privately Held (backing)

Developer of a suction cervical stabilizer designed to reduce pain and eliminate the risk of lesions and bleeding in women for gynecological purposes. Aspivix is based in Epalinges, Switzerland and was founded in 2015. Its last known valuation is $28.4 million. It has raised $20.1 million.

Last price · $/share
—
Implied valuation
$28.4M
Total raised
$20.1M
Last round
—

Who backs Aspivix?

11 investors
InvestorType
MassChallenge—
Venture KickOther
InnosuisseOther
Zürcher KantonalbankAsset manager
4FOX Ventures—
EUREKA Eurostars—
European Innovation Council (Belgium)—
Hemex (Healthcare Services)—
Horizon 2020—
Launchpad—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Aspivix investors

11 investors are on record for Aspivix, including MassChallenge, Venture Kick, Innosuisse and Zürcher Kantonalbank.

Free account
More of Aspivix with a free account
  • ·The complete investor list: 11 names
  • ·Watch Aspivix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Aspivix. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View